Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management (Q37819287)

23 August 2017

1 reference

title

Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management (English)

1 reference

23 August 2017

0 references

0 references

frontotemporal dementia

1 reference

0 references

0 references

John R Hodges

1 reference

23 August 2017

Eneida Mioshi

1 reference

23 August 2017

language of work or name

1 reference

10 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

162-172

1 reference

The prevalence of frontotemporal dementia

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Semantic dementia: a unique clinicopathological syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Primary progressive aphasia: clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

The overlap of amyotrophic lateral sclerosis and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

The evolution and pathology of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

The heritability and genetics of frontotemporal lobar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Staging disease severity in pathologically confirmed cases of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Distribution of brain atrophy in behavioral variant frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

A new subtype of frontotemporal lobar degeneration with FUS pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Clinicopathological correlates in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal lobar degeneration: clinical and pathological relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

CSF biomarkers in frontotemporal lobar degeneration with known pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Serum biomarker for progranulin-associated frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Low Serum Progranulin Predicts the Presence of Mutations: A Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Emotion, social functioning and activities of daily living in frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Executive dysfunction in frontotemporal dementia and corticobasal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Selective functional, regional, and neuronal vulnerability in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal dementia presenting as pathological gambling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Fronto-temporal dementia presenting as Geschwind's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Characteristics of abnormal eating behaviours in frontotemporal lobar degeneration: a cross-cultural survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

The case of a 48 year-old woman with bizarre and complex delusions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Behavioral disorders in the frontal and temporal variants of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Behavioral disturbances in the course of frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

The clinical picture of frontotemporal dementia: diagnosis and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Cognitive function and psychiatric symptoms in early- and late-onset frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Is early-onset clinically different from late-onset frontotemporal dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Behavioural variant frontotemporal dementia: not all it seems?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Can progressive and non-progressive behavioural variant frontotemporal dementia be distinguished at presentation?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Activities of daily living in frontotemporal dementia and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Measuring progression in frontotemporal dementia: implications for therapeutic interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Pathologically proven frontotemporal dementia presenting with severe amnesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

How preserved is episodic memory in behavioral variant frontotemporal dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Ventromedial frontal cortex mediates affective shifting in humans: evidence from a reversal learning paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Insensitivity to future consequences following damage to human prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

A neuropsychological battery to detect specific executive and social cognitive impairments in early frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Social reasoning, emotion and empathy in frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Emotion recognition in Huntington's disease and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Impaired recognition of negative facial emotions in patients with frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Structural anatomy of empathy in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Emotional reactivity and emotion recognition in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Self-conscious emotion deficits in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Empathy in frontotemporal dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Altered emotional morality in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Understanding social dysfunction in the behavioural variant of frontotemporal dementia: the role of emotion and sarcasm processing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

TASIT: A new clinical tool for assessing social perception after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal dementia as a neural system disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Development of an MRI rating scale for multiple brain regions: comparison with volumetrics and with voxel-based morphometry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Early frontotemporal dementia targets neurons unique to apes and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Neurodegenerative diseases target large-scale human brain networks

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Caudate atrophy on MRI is a characteristic feature of FTLD-FUS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Deformation-based morphometry reveals brain atrophy in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Patterns of white matter atrophy in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Rates of global and regional cerebral atrophy in AD and frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Imaging beta-amyloid burden in aging and dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

In vivo amyloid imaging with PET in frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Profiles of decline in activities of daily living in non-Alzheimer dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Neuroanatomical correlates of behavioural disorders in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Rate of progression differs in frontotemporal dementia and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Driving abilities in frontotemporal dementia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Rate of change of functional abilities in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Clinical staging and disease progression in frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal dementia progresses to death faster than Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Determinants of survival in behavioral variant frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Natural history of frontotemporal dementia: comparison with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Survival in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Rivastigmine in frontotemporal dementia: an open-label study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Frontotemporal dementia: therapeutic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Caregiver burden, health-related quality of life and coping in dementia caregivers: a comparison of frontotemporal dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Zarit burden inventory and activities of daily living in the behavioral variant of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

Factors underlying caregiver stress in frontotemporal dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970299-4

7 January 2021

10.1016/S1474-4422(10)70299-4

Identifiers

DOI

1 reference

23 August 2017

1 reference